FDA Adverse Event Malfunction Summary report: N

ELECSYS PROLACTIN ASSAY

MDR report key: 7319958 · Received March 7, 2018

Report

Report Number
1823260-2018-00666
Event Type
Malfunction
Date Received
March 7, 2018
Date of Event
January 9, 2018
Report Date
March 20, 2018
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CFT
PMA / PMN Number
K964748
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

EXPIRATION DATE WAS UPDATED. THE CUSTOMER BEGAN TO QUESTION THE PROLACTIN III RESULTS WHEN THEY SWITCHED FROM THE COBAS 8000 E 602 MODULE TO THE E801 MODULE. A METHOD COMPARISON WAS PERFORMED BETWEEN A COBAS E801 MODULE AND AN E602 MODULE AT THE INVESTIGATION SITE. REAGENT LOT 172258 WAS USED WITH THE E801 MODULE AT THE INVESTIGATION SITE. CALIBRATION AND QC WERE ACCEPTABLE. THE CUSTOMER SUBMITTED THE 40 PATIENT SAMPLES FOR INVESTIGATION. THE RESULTS FROM THE INVESTIGATION SHOW EXCELLENT COMPARABILITY BETWEEN THE E602 MODULE AND E801 MODULE. BASED ON THE INVESTIGATION RESULTS, A GENERAL REAGENT ISSUE CAN BE EXCLUDED. THE INVESTIGATION WAS UNABLE TO FIND A DEFINITIVE ROOT CAUSE.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6). (B)(4).

Description of Event or Problem · 1

THE CUSTOMER IS QUESTIONING RESULTS FOR MULTIPLE PATIENTS TESTED FOR ELECSYS PROLACTIN II (PROLACTIN II) ON A COBAS E801 MODULE. THE CUSTOMER COLLECTED 40 PATIENT SAMPLES THAT HAD BEEN TESTED ON THE E801 MODULE AND REPEATED THE SAMPLES BY THE ABBOTT ARCHITECT METHOD. BASED ON THE DATA PROVIDED, THE RESULTS FOR 23 PATIENT SAMPLES WERE DISCREPANT. THE INITIAL RESULTS FROM THE E801 MODULE HAD BEEN REPORTED OUTSIDE OF THE LABORATORY. REFER TO THE ATTACHED DATA FOR PATIENT RESULTS WITH GENDER AND AGE. THERE WAS NO ALLEGATION THAT AN ADVERSE EVENT OCCURRED. THE E801 MODULE SERIAL NUMBER WAS NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
165796 ELECSYS PROLACTIN ASSAY RADIOIMMUNOASSAY, PROLACTIN (LACTOGEN) CFT ROCHE DIAGNOSTICS NA 172258

Patients

Seq Age Sex Outcome Treatment
1 61 YR